ITGR
Integer Holdings Corporation
ITGR has a slight edge over NVO overall on the model score.
NVO
Novo Nordisk A/S
NVO has slightly lower modeled downside risk, despite its lower overall score.
ITGR Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Weak |
ITGR's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is weak.
NVO Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Healthy |
NVO's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
ITGR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 19x | $126 | — |
| Cheap | 27x | $81.88 | -35% |
| Fair | 34x | $103 | -18% |
| Expensive | 42x | $127 | +0.3% |
| Current | 42x | $126 | — |
Historical ranges are pointers, not guarantees.
ITGR's PE is in its expensive range at 42x. If earnings grow as analysts expect, today's price would be 19x next year's earnings, in its cheap range.
NVO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 10x | $40.65 | — |
| Cheap | 14x | $53.56 | +32% |
| Fair | 27x | $103 | +154% |
| Expensive | 39x | $152 | +273% |
Historical ranges are pointers, not guarantees.
NVO has the edge over ITGR in the historical PE scenario, which offers more potential upside but is not a forecast.
ITGR Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| High |
Analysts expect ITGR's earnings to grow and its profitability to improve, with its revenue holding steady.
NVO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Stable | |
| Growth | |
| Weakening | |
| Limited | |
| Low |
Analysts expect NVO's revenue to grow, but its profitability to weaken. However, they disagree widely on these estimates.
ITGR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $6.59 | +120% |
| Q3 2026 | $3.00 | +26% |
| Q2 2026 | $3.68 | +62% |
| Q1 2026 | $4.03 | +91% |
| Q4 2025 | $2.89 | -14% |
| Q3 2025 | $2.39 | -26% |
| Q2 2025 | $2.27 | -26% |
| Q1 2025 | $2.11 | -27% |
| Q4 2024 | $3.36 | +25% |
ITGR earned $3.00 per share over the past year, up 26% from the year before.
NVO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $3.89 | +4.9% |
| Q1 2026 | $4.07 | +17% |
| Q4 2025 | $3.42 | +1.8% |
| Q3 2025 | $3.47 | +10% |
| Q2 2025 | $3.71 | +24% |
| Q1 2025 | $3.49 | +18% |
| Q4 2024 | $3.36 | +21% |
| Q3 2024 | $3.15 | +27% |
NVO has the edge over ITGR on earnings, with more consistent year-over-year improvement.
ITGR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $449.7M | -3.9% |
| Q2 2026 | $464.1M | -2.6% |
| Q1 2026 | $439.6M | +0.5% |
| Q4 2025 | $472.1M | +5% |
| Q3 2025 | $467.7M | +8.4% |
| Q2 2025 | $476.5M | +9.2% |
| Q1 2025 | $437.4M | +5.4% |
| Q4 2024 | $449.5M | +8.8% |
ITGR's revenue grew through 2024 and has held roughly level since: $450M last quarter, down 3.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 6.3% | -5.8 points |
| Q2 2026 | 7.4% | -5 points |
| Q1 2026 | 7.3% | -4.1 points |
| Q4 2025 | 12% | -0.8 points |
| Q3 2025 | 12% | -1.4 points |
| Q2 2025 | 12% | -0.2 points |
| Q1 2025 | 11% | +1.9 points |
| Q4 2024 | 13% | +2.2 points |
ITGR's operating margin was 6.3% last quarter, down 5.8 points from the same quarter a year ago, near the bottom of its range since 2019.
NVO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $11.7B | +2.1% |
| Q1 2026 | $14.4B | +24% |
| Q4 2025 | $11.8B | -7.6% |
| Q3 2025 | $11.1B | +5.1% |
| Q2 2025 | $11.4B | +13% |
| Q1 2025 | $11.6B | +19% |
| Q4 2024 | $12.7B | +30% |
| Q3 2024 | $10.6B | +21% |
NVO has the edge over ITGR on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 34% | -9 points |
| Q1 2026 | 62% | +12 points |
| Q4 2025 | 40% | -2.8 points |
| Q3 2025 | 32% | -16 points |
| Q2 2025 | 44% | +5.4 points |
| Q1 2025 | 50% | +1 points |
| Q4 2024 | 43% | +2.2 points |
| Q3 2024 | 47% | +1.6 points |
NVO has the edge over ITGR on profitability, with a higher operating margin.
ITGR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $16.1M | -65% |
| Q2 2026 | $37M | +49% |
| Q1 2026 | $737K | -88% |
| Q4 2025 | $27.9M | -37% |
| Q3 2025 | $46.3M | +1.7% |
| Q2 2025 | $24.9M | +55% |
| Q1 2025 | $6.1M | +$11.9M |
| Q4 2024 | $44.1M | +138% |
ITGR still generates free cash flow, though less than at its 2020 peak: $82M over the past year.
NVO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $6.3B | +73% |
| Q1 2026 | $1.8B | +20% |
| Q4 2025 | -$5.4B | -$4.7B |
| Q3 2025 | $4.6B | -2.1% |
| Q2 2025 | $3.6B | -34% |
| Q1 2025 | $1.5B | +89% |
| Q4 2024 | -$632.6M | +$390.5M |
| Q3 2024 | $4.7B | +3.3% |
NVO still generates free cash flow, though less than at its 2026 peak: $7.3B over the past year.
ITGR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.3% | +459K shares |
| 1 year | -2.8% | -1M shares |
| 3 years | +2.5% | +830K shares |
| 5 years | +3.9% | +1.3M shares |
| Available history | +4.7% | +1.6M shares |
ITGR has the edge over NVO on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $50M |
NVO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -12.9M shares |
| 1 year | -0.2% | -11M shares |
| 3 years | -1.5% | -66.8M shares |
| 5 years | -3.8% | -177M shares |
| Available history | -6.5% | -311M shares |
NVO has 4.4B diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | $520M |
| Q1 2026 | $356.7M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $206.3M |
| Q4 2024 | $1.1B |
| Q3 2024 | $357.4M |
NVO spent $877M buying back its own shares over the past year, down 48% from the year before.
ITGR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 4.2x | High |
| Q2 2026 | 3.8x | Elevated |
| Q1 2026 | 3.7x | Elevated |
| Q4 2025 | 3.3x | Elevated |
| Q3 2025 | 3.3x | Elevated |
| Q2 2025 | 3.4x | Elevated |
| Q1 2025 | 3.6x | Elevated |
| Q4 2024 | 2.9x | Moderate |
ITGR's net debt is about 4.2 years of its operating earnings (EBITDA), up from 3.3 years a year ago.
NVO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.7x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.4x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.6x | Very low |
| Q3 2024 | -0.0x | Very low |
NVO has the edge over ITGR on leverage, with a lower net debt burden relative to earnings.
ITGR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 81.1 | Overbought |
| Stochastic | 89.2 | Overbought |
ITGR's weekly RSI is 81 (overbought) and its Stochastic is 89 (overbought).
NVO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.0 | Neutral |
| Stochastic | 27.0 | Neutral |
NVO's weekly RSI is 43 (neutral) and its Stochastic is 27 (neutral).
ITGR PE vs Healthcare Sector
| Metric | ITGR | Sector median | Relative |
|---|---|---|---|
| PE | 42x | 26x | 63% above |
| PE % | 80 | 29 | 51 pts above |
ITGR is trading at 42x earnings, a 63% premium to the Healthcare sector's median of 26x.
NVO PE vs Healthcare Sector
| Metric | NVO | Sector median | Relative |
|---|---|---|---|
| PE | 10x | 26x | 60% below |
| PE % | 6 | 29 | 23 pts below |
NVO has the edge over ITGR on valuation relative to its sector.
ITGR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $126.5 | 0.1% below |
| 20 week MA | $119.8 | 5.5% above |
| 50 week MA | $99.0 | 28% above |
| 100 week MA | $106.1 | 19% above |
| 200 week MA | $103.5 | 22% above |
ITGR has the edge over NVO on trend strength, trading above more of its moving averages.
NVO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $39.2 | 3.7% above |
| 20 week MA | $43.9 | 7.4% below |
| 50 week MA | $45.3 | 10% below |
| 100 week MA | $56.3 | 28% below |
| 200 week MA | $80.7 | 50% below |
NVO has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 50% below its 200-week average.
ITGR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $81.2 | $81.6 | +0.5% |
| 2021 | $81.6 | $85.8 | +5.1% |
| 2022 | $85.8 | $67.9 | -21% |
| 2023 | $67.9 | $99.1 | +46% |
| 2024 | $99.1 | $134.8 | +36% |
| 2025 | $134.8 | $78.9 | -41% |
| 2026 YTD | $78.9 | $126.4 | +60% |
ITGR has the edge over NVO on returns for 2026, with the stronger performance.
NVO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $29.1 | $34.7 | +19% |
| 2021 | $34.7 | $54.2 | +56% |
| 2022 | $54.2 | $67.0 | +24% |
| 2023 | $67.0 | $103.5 | +54% |
| 2024 | $103.5 | $87.4 | -16% |
| 2025 | $87.4 | $52.4 | -40% |
| 2026 YTD | $52.4 | $40.7 | -22% |
NVO has finished higher in four of the last six years, two of them by more than 50%. It's down 22% so far in 2026.